Gold Nanoparticles As Novel Agents for Cancer Therapy

Overview

Journal Br J Radiol

Publisher Oxford University Press

Specialty Radiology

Date 2011 Oct 20

PMID 22010024

Citations 240

Authors

S Jain

D G Hirst

J M OSullivan

Affiliations

Soon will be listed here.

Abstract

Gold nanoparticles are emerging as promising agents for cancer therapy and are being investigated as drug carriers, photothermal agents, contrast agents and radiosensitisers. This review introduces the field of nanotechnology with a focus on recent gold nanoparticle research which has led to early-phase clinical trials. In particular, the pre-clinical evidence for gold nanoparticles as sensitisers with ionising radiation in vitro and in vivo at kilovoltage and megavoltage energies is discussed.

Citing Articles

An Evaluation of the Potential Radiosensitization Effect of Spherical Gold Nanoparticles to Induce Cellular Damage Using Different Radiation Qualities.

Engelbrecht-Roberts M, Miles X, Vandevoorde C, de Kock M Molecules. 2025; 30(5).

PMID: 40076263 PMC: 11902069. DOI: 10.3390/molecules30051038.

Synergistic Nanoformulation: Streamlined One-Pot Synthesis Enhances Paclitaxel Functionalization Gold Nanoparticles for Potent Anticancer Activity.

Velhal K, Sah P, Naik H, Raut R, Patil S, Yamgar R Cell Biochem Biophys. 2025; .

PMID: 40011315 DOI: 10.1007/s12013-025-01701-w.

Emerging Role of Hypoxia-Inducible Factors (HIFs) in Modulating Autophagy: Perspectives on Cancer Therapy.

Jalouli M Int J Mol Sci. 2025; 26(4).

PMID: 40004215 PMC: 11855875. DOI: 10.3390/ijms26041752.

Recent advances in improved efficacies of gold nano-formulations in treatment of skin cancer: a systematic review.

Heydari M, Saifi M, Ghanbari-Movahed M, Salari N, Faghihi S, Mohammadi M Arch Dermatol Res. 2025; 317(1):301.

PMID: 39833557 DOI: 10.1007/s00403-025-03817-8.

Characterization and evaluation of the cytotoxic, antioxidant, and anti-human lung cancer properties of copper nanoparticles green-synthesized by fennel extract following the PI3K/AKT/Mtor signaling pathway.

Huang T, Ma K, Wang Y PLoS One. 2025; 20(1):e0309207.

PMID: 39787250 PMC: 11717185. DOI: 10.1371/journal.pone.0309207.

References

Morton G . The emerging role of high-dose-rate brachytherapy for prostate cancer. Clin Oncol (R Coll Radiol). 2005; 17(4):219-27. DOI: 10.1016/j.clon.2004.12.005. View

Ranjan Patra C, Bhattacharya R, Mukhopadhyay D, Mukherjee P . Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev. 2009; 62(3):346-61. PMC: 2827658. DOI: 10.1016/j.addr.2009.11.007. View

Kang B, Mackey M, El-Sayed M . Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. J Am Chem Soc. 2010; 132(5):1517-9. DOI: 10.1021/ja9102698. View

Liu C, Wang C, Chen S, Chen H, Leng W, Chien C . Enhancement of cell radiation sensitivity by pegylated gold nanoparticles. Phys Med Biol. 2010; 55(4):931-45. DOI: 10.1088/0031-9155/55/4/002. View

Ranjan Patra C, Bhattacharya R, Wang E, Katarya A, Lau J, Dutta S . Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res. 2008; 68(6):1970-8. DOI: 10.1158/0008-5472.CAN-07-6102. View

Patra H, Banerjee S, Chaudhuri U, Lahiri P, Dasgupta A . Cell selective response to gold nanoparticles. Nanomedicine. 2007; 3(2):111-9. DOI: 10.1016/j.nano.2007.03.005. View

Roa W, Zhang X, Guo L, Shaw A, Hu X, Xiong Y . Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology. 2009; 20(37):375101. DOI: 10.1088/0957-4484/20/37/375101. View

Essig M, Debus J, Schlemmer H, Hawighorst H, Wannenmacher M, van Kaick G . [Improved tumor contrast and delineation in the stereotactic radiotherapy planning of cerebral gliomas and metastases with contrast media-supported FLAIR imaging]. Strahlenther Onkol. 2000; 176(2):84-94. DOI: 10.1007/pl00002333. View

Service R . American Chemical Society meeting. Nanomaterials show signs of toxicity. Science. 2003; 300(5617):243. DOI: 10.1126/science.300.5617.243a. View

10.

Issels R, Lindner L, Verweij J, Wust P, Reichardt P, Schem B . Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 2010; 11(6):561-70. PMC: 3517819. DOI: 10.1016/S1470-2045(10)70071-1. View

11.

Garnica-Garza H . Contrast-enhanced radiotherapy: feasibility and characteristics of the physical absorbed dose distribution for deep-seated tumors. Phys Med Biol. 2009; 54(18):5411-25. DOI: 10.1088/0031-9155/54/18/004. View

12.

Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H . Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002; 3(8):487-97. DOI: 10.1016/s1470-2045(02)00818-5. View

13.

Vernon C, Hand J, FIELD S, Machin D, WHALEY J, van der Zee J . Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys. 1996; 35(4):731-44. DOI: 10.1016/0360-3016(96)00154-x. View

14.

Fang J, Nakamura H, Maeda H . The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2010; 63(3):136-51. DOI: 10.1016/j.addr.2010.04.009. View

15.

van der Zee J, Gonzalez Gonzalez D, van Rhoon G, van Dijk J, van Putten W, Hart A . Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet. 2000; 355(9210):1119-25. DOI: 10.1016/s0140-6736(00)02059-6. View

16.

Chang E, Thekkek N, Yu W, Colvin V, Drezek R . Evaluation of quantum dot cytotoxicity based on intracellular uptake. Small. 2006; 2(12):1412-7. DOI: 10.1002/smll.200600218. View

17.

Stern J, Cadeddu J . Emerging use of nanoparticles for the therapeutic ablation of urologic malignancies. Urol Oncol. 2008; 26(1):93-6. DOI: 10.1016/j.urolonc.2007.03.019. View

18.

Roeske J, Nunez L, Hoggarth M, Labay E, Weichselbaum R . Characterization of the theorectical radiation dose enhancement from nanoparticles. Technol Cancer Res Treat. 2007; 6(5):395-401. DOI: 10.1177/153303460700600504. View

19.

Stern S, Hall J, Yu L, Wood L, Paciotti G, Tamarkin L . Translational considerations for cancer nanomedicine. J Control Release. 2010; 146(2):164-74. PMC: 2921639. DOI: 10.1016/j.jconrel.2010.04.008. View

20.

Zheng Y, Sanche L . Gold nanoparticles enhance DNA damage induced by anti-cancer drugs and radiation. Radiat Res. 2009; 172(1):114-9. DOI: 10.1667/RR1689.1. View